Emendo Biotherapeutics

📍 New York, United States🗓 Founded 2015👥 113 employees💰 Last funded Jan 2020
Biotechnology Research🌐 emendobio.com
Website LinkedIn
Emendo Biotherapeutics develops next generation gene editing tools for genetic disorders, addressing the current technological gaps for realizing the promise of gene therapy. We leverage our expertise in protein engineering to bring innovative and disruptive protein tools to resolve the bottleneck of the field.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in Emendo Biotherapeutics?
Emendo Biotherapeutics has 1 investor on record on gritt.io, 1 mid-stage.
When did Emendo Biotherapeutics last raise funding?
The most recent investment in Emendo Biotherapeutics recorded on gritt.io was in January 2020.
When was Emendo Biotherapeutics founded?
Emendo Biotherapeutics was founded in 2015.
What industry is Emendo Biotherapeutics in?
Emendo Biotherapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Emendo Biotherapeutics based?
Emendo Biotherapeutics is headquartered in New York, United States.